Introduction {#s1}
============

The insulin-like growth factor-I (IGF-I) signaling pathway stimulates cell proliferation and inhibits apoptosis [@pone.0002578-Sachdev1], [@pone.0002578-Wood1]. The bioavailability of IGF-I in circulation and tissues is determined by the amount of free ligand that circulates unattached to binding protein. There are six IGF binding proteins. Approximately 75--90% of IGF-I binds to IGFBP-3, limiting its bioavailability. IGFBP-1 also modulates IGF-I bioavailability, and is inversely regulated by insulin [@pone.0002578-Baxter1]. IGF-I has been shown to promote proliferation of normal epithelial breast cells [@pone.0002578-Sachdev1], [@pone.0002578-Wood1], [@pone.0002578-Burger1]. The IGF pathway has been linked to mammary carcinogenesis in animal models [@pone.0002578-Hadsell1], and consequently, it has been extensively examined in relation to breast cancer pathogenesis.

Previous epidemiologic studies have suggested that high circulating levels of IGF-I and low levels of IGFBP-3 are associated with increased risk of premenopausal breast cancer [@pone.0002578-Fletcher1], [@pone.0002578-Allen1]. Numerous recent epidemiologic studies (reviewed in [@pone.0002578-Fletcher1]) have begun to examine variation in the genes encoding *IGF1, IGFBP1*, and *IGFBP3* in relation to breast cancer risk. The most extensively examined polymorphisms in *IGF1* has been the 5′ simple tandem repeat that lies 1-kb upstream from the *IGF1* gene transcription start site (the most common allele in Caucasians is the 19 CA repeat) and an A/C polymorphism 5′ to *IGFBP3* at nucleotide −202 (rs2854744) [@pone.0002578-Fletcher1]. Some studies report that these or other *IGF* polymorphisms modestly affect circulating levels of IGF-I and IGFBP-3 [@pone.0002578-Fletcher1], [@pone.0002578-Canzian1], [@pone.0002578-Cheng1], [@pone.0002578-Johansson1], [@pone.0002578-Setiawan1], [@pone.0002578-Verheus1], but there is limited support for a direct effect on breast cancer risk. Most recently, comprehensive analyses of common genetic variation across the *IGF1, IGFBP1*, and *IGFBP3* genes were conducted in two prospective cohorts [@pone.0002578-Canzian1], [@pone.0002578-Cheng1], [@pone.0002578-Setiawan1], but no association with breast cancer risk was observed.

To comprehensively examine the role of common genetic variation in the *IGF1, IGFBP1*, and *IGFBP3* genes in relation to circulating IGF-I and IGFBP-3 levels and breast cancer risk, we conducted a haplotype-based analysis in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3) [@pone.0002578-Hunter1]. The large size of this study (cases = 6,912/controls = 8,891) enabled us to detect modest genetic effects, explore gene-environment interactions, and examine potentially important subclasses of tumors, such as those defined by stage or hormone receptor status.

Methods {#s2}
=======

Study Population {#s2a}
----------------

The BPC3 has been described in detail elsewhere [@pone.0002578-Hunter1]. Briefly, the consortium includes large well-established cohorts assembled in the United States or Europe that have DNA for genotyping and extensive questionnaire data from cohort members. This analysis includes 6,912 cases of invasive breast cancer and 8,891 matched controls from six cohorts: the American Cancer Society Cancer Prevention Study-II (CPS-II; [@pone.0002578-Calle1]), the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort [@pone.0002578-Riboli1], the Harvard Nurses\' Health Study (NHS; [@pone.0002578-Colditz1]), the Harvard Women\'s Health Study (WHS; [@pone.0002578-Rexrode1]), the Hawaii-Los Angeles Multiethnic Cohort Study (MEC; [@pone.0002578-Kolonel1]), and the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial cohort (PLCO; [@pone.0002578-Hayes1]). With the exception of MEC, most women in these studies are Caucasian. Written informed consent was obtained from all subjects, and each cohort has been approved by the following institutional review boards: Emory University (CPS-II), International Agency for Research on Cancer (IARC) and each EPIC recruitment center (EPIC), Harvard University (NHS and WHS), University of Hawaii and University of Southern California (MEC), and the U.S. National Cancer Institute and the 10 study screening centers (PLCO).

Cases were initially identified in each cohort by self-report and subsequently verified from medical records or tumor registries and/or linkage with population-based cancer registries. In all cohorts, questionnaire data were collected prospectively before the cancer diagnosis. Controls were matched to cases by age, ethnicity (except in PLCO), and in some cohorts additional matching criteria were utilized (e.g. date of blood draw).

SNP Selection and Genotyping {#s2b}
----------------------------

The details of *IGF1*, *IGFBP1* and *IGFBP3* characterization and selection of haplotype-tagging SNPs (htSNPs) have been described elsewhere [@pone.0002578-Cheng1], [@pone.0002578-Cheng2]. Briefly, coding regions of *IGF1, IGFBP1*, and *IGFBP3* were sequenced in a panel of 95 advanced breast cancer cases from the MEC (19 from each of the five ethnic groups; African American, Latina, Japanese, Native Hawaiian, and Caucasian). SNPs were also selected from public databases to capture the genetic diversity of regions from ∼20 kb upstream to ∼10 kb downstream of each gene. Haplotype blocks (regions of strong linkage disequilibrium) were defined using the method of Gabriel et al. [@pone.0002578-Gabriel1]. Haplotype tagging SNPs (htSNPs) were selected to predict the common haplotypes among Caucasians that meet a criterion of r~h~ ^2^\>0.80.

For genetic characterization of *IGF1*, 154 SNPs were genotyped a multiethnic panel of 349 individuals with no history of cancer *(18)*. Of the 154 SNPs genotyped, 53 were identified as monomorphic and 37 had poor genotyping results (i.e., genotyped ≤75% of samples or out of Hardy-Weinberg equilibrium \[one-sided *P*\<.01\] in more than one ethnic group)---these 90 SNPs were eliminated from further analysis. The remaining 64 SNPs were used for genetic characterization and had an average density of one SNP for every 2.4 kb over a 156-kb region. Fourteen htSNPs were selected using the expectation-maximization algorithm [@pone.0002578-Stram1] to predict the common haplotypes among Caucasians (r~h~ ^2^\>0.85). For genetic characterization of *IGFBP1* and *IGFBP3* (which are located contiguously in a 35kb region of chromosome 7), 56 SNPs were genotyped in the multiethnic panel *(18)*. Of the 56 SNPs genotyped, 17 were identified as monomorphic and 3 had poor genotyping results (as discussed above)---these 20 SNPs were eliminated from analysis. The remaining 36 SNPs were used for genetic characterization, having an average density of one SNP for every 2 kb over a 71-kb region. Twelve htSNPs were selected to predict the common haplotypes among Caucasians (r~h~ ^2^\>0.99). Additionally, two genic SNPs in *IGFBP3* that were not part of a haplotype block were examined (rs6670, rs2453839), and two additional *IGFBP3* SNPs (rs2132570, and rs2960436) were included. Thus, a total of 16 SNPs across *IGFBP1* and *IGFBP3* were evaluated. Genotyping of breast cancer cases and controls was performed in four laboratories (University of Southern California, Los Angeles, CA USA, Harvard School of Public Health, Boston, MA USA, International Agency for Research on Cancer, Lyon, France, National Cancer Institute Core Genotyping Facility, Gaithersburg, MD USA) using a fluorescent 5′ endonuclease assay and the ABI-PRISM 7900 for sequence detection (Taqman). Initial quality control checks of the SNP assays were done at the manufacturer (ABI, Foster City, CA); an additional 500 test reactions were run by the BPC3. Assay characteristics for the *IGF1*, *IGFBP1*, and *IGFBP3* htSNPs are available on a public website (<http://www.uscnorris.com/mecgenetics/CohortGCKView.aspx>). To assess interlaboratory variation, each genotyping center ran assays on a designated set of 94 samples from the Coriell Biorepository (Camden, NJ) (22). The completion and concordance rates were each \>99%[@pone.0002578-Packer1]. The internal quality of genotype data at each genotyping center was assessed by typing 5--10% blinded samples in duplicate or greater, depending on study.

IGF-I and IGFBP-3 Measurements {#s2c}
------------------------------

IGF-I and IGFBP-3 levels were measured by enzyme-linked immunosorbent assays among non-users of postmenopausal hormones (and non-users of oral contraceptives in EPIC). Detailed laboratory methods for these studies have been previously reported [@pone.0002578-DeLellis1], [@pone.0002578-Rinaldi1], [@pone.0002578-Schernhammer1]. Blood samples analyzed in this study include all cohorts with the exception of the CPS-II and WHS cohorts, where most specimens were collected after diagnosis (CPS-II) or hormone assays were not performed (WHS). Thus, these analyses included 6,410 women for IGF-I and 6,275 women for IGFBP-3.

Statistical Analysis {#s2d}
--------------------

In our hormone analyses, circulating IGF-I and IGFBP-3 values were naturally log-transformed to provide approximate normal distributions. Geometric mean levels of IGF-I and IGFBP-3 for *IGF1* and *IGFBP3* SNPs were calculated using linear regression analysis while adjusting for age at blood draw, assay laboratory and batch for circulating IGFs, BMI, race/ethnicity, and country within EPIC cohort. Additional regression analyses were conducted simultaneously adjusted for all other *IGF1* and *IGFBP* SNPs to determine the best fit model of circulating levels.

In our breast cancer analysis, we examined both single SNP and haplotype effects on breast cancer risk. For single SNP analyses, we used conditional multivariate logistic regression to estimate odds ratios (ORs) for breast cancer using a linear (log-odds additive) scoring for 0, 1 or 2 copies of the minor allele of each SNP. For the haplotype analyses, we calculated haplotype frequencies and subject-specific expected haplotype counts separately for each cohort, by country within EPIC, and by ethnicity within the MEC. An expectation-substitution approach was used to assign expected haplotype counts based on unphased genotype data and to account for uncertainty in assignment [@pone.0002578-Zaykin1]. The most common haplotype was used as the referent group. Rare haplotypes (those with estimated individual frequencies \<5%) were combined into a single category.

To test the global null hypothesis of no association between variation in *IGF1*, *IGFBP1*, or *IGFBP3* haplotypes and risk of breast cancer (or subtypes defined by receptor status), we used a likelihood ratio test comparing a model with additive effects for each common haplotype (treating the most common haplotype as the referent) to the intercept-only model. To test for heterogeneity across cohorts and ethnic groups, we used the Wald *X* ^2^ for the htSNPs and a likelihood ratio test for the haplotypes.

We considered conditional models both without and with adjustment for known breast cancer risk factors. These included menopausal status (premenopausal, postmenopausal), age at menopause (\<50, 50+, age unknown), BMI (\<25, 25-\<30, 30+, missing), parity (ever, never, missing), use of postmenopausal hormones (ever, never, missing), first-degree family history of breast cancer (yes, no, unknown), age at menarche (\<13, 13--14, 15+, missing), and use of oral contraceptives (ever, never, missing). Because results remained virtually unchanged regardless of the model used, we present results from the conditional models adjusting for matching factors only. We also evaluated BMI, family history of breast cancer, and use of postmenopausal hormones for possible interaction effects using likelihood ratio testing (LRT). Models with the main effect of genotype and the covariate of interest were compared to models with the main effects of genotype and the covariate of interest, plus a multiplicative interaction term of the two variables. We also examined whether the associations between *IGF1, IGFBP1*, or *IGFBP3* htSNPs or haplotypes and breast cancer differed by menopausal status (pre- versus post-menopausal), stage (*in situ* versus localized versus regional or distant metastasis) or hormone receptor (ER and PR) status.

Lastly, this analysis includes a portion of the previously published data from the MEC [@pone.0002578-Cheng1], [@pone.0002578-Setiawan1] and EPIC [@pone.0002578-Canzian1] cohorts (n = 2,522 breast cancer cases). Thus, all associations were examined in sub-analyses that excluded the MEC and EPIC cohort participants.

Results {#s3}
=======

The genomic structure of *IGF1* is shown in [Fig. 1](#pone-0002578-g001){ref-type="fig"} and that of *IGFBP1* and *IGFBP3* is shown in [Fig. 2](#pone-0002578-g002){ref-type="fig"}. The *IGF1* locus was characterized into four haplotype blocks. *IGFBP1* and *IGFBP3* loci are 19kb apart and were characterized by three haplotype blocks. The genotyping success rate was ≥95% for all SNPs at each genotyping center. No deviation from Hardy-Weinberg equilibrium was observed among the controls overall (at the p\<0.01 level). The frequencies of individual SNPs and common haplotypes within each LD block were consistent across all cohorts (data not shown).

![IGF1 SNPs and linkage disequilibrium.\
64 SNPs were identified covering a 56-kb region. Of these, 14 htSNPs defined the common haplotypes among Caucasians.](pone.0002578.g001){#pone-0002578-g001}

![IGFBP1 and IGFBP3 SNPs and linkage disequilibrium.\
36 SNPs were identified covering a 71-kb region. Of these, 12 htSNPs defined the common haplotypes among Caucasians.](pone.0002578.g002){#pone-0002578-g002}

Study characteristics of each cohort (except PLCO) have been published previously [@pone.0002578-Feigelson1]. Briefly, case and control characteristics were comparable across all cohorts and most women were postmenopausal (n = 5,474 cases and 9,732 controls) and Caucasian. As there was no heterogeneity in results across cohorts for any main effects analyses, we only reported results from pooled analyses across all cohorts combined. Additionally, haplotype analyses did not contribute additional information beyond individual SNP results, thus we reported only results for all individual SNPs within each haplotype block.

SNPs in *IGF1* ([Table 1](#pone-0002578-t001){ref-type="table"}) and *IGFBP3* ([Table 2](#pone-0002578-t002){ref-type="table"}) were associated with circulating IGF-I and IGFBP-3 levels, respectively, in women not taking postmenopausal hormones. SNPs in *IGF1* block 1 were most closely associated with circulating levels; the variant alleles were significantly associated with higher circulating IGF-I levels (trend p = 0.0075 for rs7965399 and p = 0.0262 for rs35767). However, these SNPs (wild type vs. variant homozygote) individually accounted for less than a 5% change in mean IGF-I levels. Results did not differ after simultaneously adjusting for all other *IGF1* and *IGFBP* SNPs in the regression analysis (data not shown). The strongest relationships for IGFBP-3 were observed with five SNPs in *IGFBP3* block 3: rs3110697, rs2854746, rs2854744, rs2132570, rs2960436 (trend p\<0.001 for all). Rs2854746 remained significantly associated with IGFBP-3 levels (p\<0.0001) after adjusting for all other *IGF1* and *IGFBP* SNPs simultaneously in the regression analysis. These SNP associations account for a change in mean circulating IGFBP-3 levels ranging from 6% (rs2132570) to 12% (rs2854746).

10.1371/journal.pone.0002578.t001

###### Associations between IGF1 SNPs and mean circulating IGF-I and IGFBP-3 levels in the BPC3.
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  SNP (position)    Genotype   N (n = 6,410)   mean IGF1 diff   p-trend   \% change   N (n = 6,410)   mean IGFBP-3 diff   p-trend   \% change
  ---------------- ---------- --------------- ---------------- --------- ----------- --------------- ------------------- --------- -----------
  **Block 1**                                                                                                                      
  rs7965399            TT          5620             26.8                      0           5495              122.1                       0
  (101394153)          TC           530             28.0         0.008       4.4           522              119.9          0.075      −1.8
                       CC           41              28.1                     4.8           41               112.7                     −8.3
  rs35767              GG          4184             26.9                      0           4100              121.5                       0
  (101378036)          GA          1704             27.4         0.026       1.8          1662              120.6          0.049      −0.7
                       AA           209             27.9                     3.7           205              115.3                     −5.4
  **Block 2**                                                                                                                      
  rs12821878           GG          3830             27.1                      0           3751              121.6                       0
  (101370134)          GA          2039             26.8         0.187      −1.3          1993              122.1          0.164       0.4
                       AA           326             26.8                    −1.3           317              125.2                       3
  rs1019731            CC          4826             27.2                      0           4718              121.5                       0
  (101366892)          CA          1312             27.1         0.915      −0.5          1288              121.4          0.856      −0.1
                       AA           103             28.1                     3.3           101              123.5                      1.6
  rs2195239            CC          3754             26.8                      0           3673              121.3                       0
  101359169            CG          2182             27.4         0.028       2.3          2134              121.3          0.932        0
                       GG           330             27.2                     1.7           326              121.2                       0
  **Block 3**                                                                                                                      
  rs10735380           AA          3397             26.8                      0           3327              122.1                       0
  (101346703)          AG          2363             27.5         0.042       2.5          2310              121.5          0.847      −0.5
                       GG           454             27.1                      1            444              122.6                      0.4
  rs2373722            GG          5405             27.1                      0           5292              121.9                       0
  (101342924)          GA           809             27.8         0.071       2.4           787               120           0.256      −1.6
                       AA           41              27.7                      2            42               122.5                      0.5
  rs5742665            CC          4690             27.1                      0           4601              121.6                       0
  (101326017)          CG          1394             27.3         0.288       0.8          1355              121.1          0.532      −0.4
                       GG           120             27.9                     3.1           113              119.8                     −1.5
  rs1549593            GG          4703             27.0                      0           4598              121.2                       0
  (101299258)          GT          1350             26.8         0.754      −0.8          1325              122.7          0.541       1.2
                       TT           99              27.7                     2.5           95               117.4                     −3.2
  rs1520220            CC          4068             26.8                      0           3976              122.4                       0
  (101298989)          CG          1902             27.7         0.007       3.1          1868               121           0.157      −1.2
                       GG           253             27.2                     1.3           249              120.5                     −1.6
  **Block 4**                                                                                                                      
  rs2946834            GG          2771             26.5                      0           2714              122.7                       0
  (101290281)          GA          2716             27.4         0.007       3.2          2658               121           0.076      −1.4
                       AA           704             27.1                     2.2           685              120.5                     −1.8
  rs4764876            GG          3259             26.9                      0           3187              121.5                       0
  (101261169)          GC          2460             27.2         0.218       1.2          2408              121.1          0.812      −0.3
                       CC           461             27.1                     1.1           451              121.4                     −0.1
  rs4764695            GG          1592             27.3                      0           1559              121.9                       0
  (101259580)          GA          3122             27.1         0.190      −0.9          3049              121.2          0.875       0.6
                       AA          1529             26.9                    −1.6          1500              122.2                      0.2
  rs1996656            AA          4307            27.00                      0           4215              120.5                       0
  (101254429)          AG          1718             27.2         0.605       0.8          1678              120.9          0.882       0.3
                       GG           185             26.9                    −0.3           182              119.9                     −0.5

10.1371/journal.pone.0002578.t002

###### Associations between IGFBP1 and IGFBP3 SNPs and mean circulating IGF-I and IGFBP-3 levels in the BPC3.

![](pone.0002578.t002){#pone-0002578-t002-2}

  SNP                    Genotype   N (n = 6,275)   mean IGF1 diff   p-trend   \% change   N (n = 6,275)   mean IGFBP-3 diff   p-trend    \% change
  --------------------- ---------- --------------- ---------------- --------- ----------- --------------- ------------------- ---------- -----------
  **Block 1**                                                                                                                            
  rs10228265                AA          3035             26.9                      0           2981              122.5                        0
  \(45649695\)              AG          2654             27.3                     1.4          2587               121                       −1.2
                            GG           599             27.3         0.108       1.7           585              120.3          0.083       −1.8
  rs1553009                 GG          4061             27.1                      0           3976              121.5                        0
  \(45649774\)              GA          1998             27.6                      2           1953              122.1                       0.5
                            AA           235             26.5         0.285       −2            232              124.4          0.270        2.4
  rs35539615                CC          3640             27.2                      0           3560              121.4                        0
  \(45653244\)              CG          2269             27.1                    −0.2          2223               121                       −0.3
                            GG           327             27.3         0.995       0.6           319              121.5          0.788        0.1
  rs2201638                 GG          5854             27.2                      0           5729              122.1                        0
  \(45663690\)              GA           413             27.6                     1.7           404              120.2                      −1.6
                            AA           17              27.7         0.349        2            17               113.1          0.209        −8
  rs1065780                 GG          2358             27.0                      0           2309               122                         0
  \(45668457\)              GA          2966             27.3                     1.1          2902              121.8                      −0.2
                            AA           923             27.3         0.262       1.1           903              121.2          0.663       −0.7
  **Block 2**                                                                                                                            
  rs4988515                 CC          5753             27.1                      0           5625              121.7                        0
  \(45673380\)              CT           522             27.2                     0.5           515              121.1                      −0.5
                            TT           19              26.1         0.909      −3.8           19               113.9          0.532       −6.8
  rs4619                    AA          2662             27.0                      0           2608              122.3                        0
  \(45673449\)              AG          2839             27.2                     0.5          2774              121.3                      −0.8
                            GG           735             27.5         0.243       1.8           719               122           0.543       −0.2
  rs1908751                 CC          3113             27.2                      0           3047              122.2                        0
  \(45676299\)              CT          2586             27.0                    −0.7          2526              120.6                      −1.3
                            TT           560             27.1         0.568      −0.3           552              122.6          0.486        0.3
  rs2270628                 CC          4121             27.3                      0           4038              122.8                        0
  \(45690350\)              CT          1850             27.1                    −0.6          1804              120.1                      −2.2
                            TT           239             27.1         0.543      −0.7           234              116.4          0.001       −5.5
  **Block 3**                                                                                                                            
  rs3110697                 GG          2203             27.4                      0           2145              125.4                        0
  \(45695809\)              GA          2929             27.1                    −1.1          2877              122.2                      −2.6
                            AA          1083             27.9         0.392       1.8          1059              115.2         \<0.0001     −8.9
  rs2854746                 GG          2010             27.3                      0           1970              114.7                        0
  \(45701425\)              GC          2950            27.00                    −0.9          2884               123                        7.2
                            CC          1168             27.2         0.741      −0.1          1139              128.5         \<0.0001      12
  rs2854744                 GG          1586             27.6                      0           1550              115.6                        0
  \(45701855\)              GT          3226             27.1                    −2.1          3169              121.5                       5.1
                            TT          1427             27.6         0.745      −0.3          1388              127.7         \<0.0001     10.5
  **Additional SNPs**                                                                                                                    
  rs6670                    TT          3841             27.3                      0           3764              121.6                        0
  \(45693034\)              TA          2146             26.8                    −2.1          2091              120.1                      −1.2
                            AA           278             26.6         0.022      −2.8           275              125.2          0.935         3
  rs2453839                 TT          4046             27.3                      0           3964              122.3                        0
  \(45694353\)              TC          1961             27.2                    −0.5          1917               121                       −1.1
                            CC           250             27.5         0.901       0.9           242              121.4          0.264       −0.7
  rs2132570                 GG          3948             27.1                      0           2855              122.4                        0
  \(45703243\)              GT          1972             27.1                    −0.2          1933              118.9                      −2.9
                            TT           291             27.5         0.812       1.3           289              115.3         \<0.0001     −6.2
  rs2960436                 GG          1645             27.6                      0           1607               115                         0
  \(45718062\)              GA          3074             27.1                    −1.7          3021              122.5                       6.5
                            AA          1547             27.3         0.431      −0.9          1506              127.2         \<0.0001     10.6

None of the *IGF1* and *IGFBP3* SNPs associated with circulating IGF-I and IGFBP-3 levels were significantly associated with breast cancer risk ([Tables 3](#pone-0002578-t003){ref-type="table"} and [4](#pone-0002578-t004){ref-type="table"} for *IGF1* and *IGFBP1/3*, respectively), nor were other SNPs or haplotypes consistently associated with risk. When examining these associations among invasive breast cancer only, by stage, or by hormone-receptor status, we did not observe any associations between variation in these genes and disease risk (data not shown). Results did not differ when examining associations separately for pre- and post-menopausal women or when restricting the analysis to only white women (data not shown). No consistent interactions were observed among variants in the *IGF1*, *IGFBP1*, and *IGFBP3* genes with any of the following: first-degree family history of breast cancer, ever oral contraceptive use, use of postmenopausal hormones, and BMI (\<25, 25-\<30, 30+). We observed no interactions resulting in sub-group associations with disease risk (data not shown).

10.1371/journal.pone.0002578.t003

###### Association of tagging SNPs of *IGF1* and breast cancer risk in the BPC3.
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  SNP                    Genotype   Cases (n = 6,912)   Controls (n = 8,891)   OR[\*](#nt101){ref-type="table-fn"} (95% CI)   p-trend
  --------------------- ---------- ------------------- ---------------------- ---------------------------------------------- ---------
  **Block 1**                                                                                                                
  rs7965399                 TT            5668                  7214                           1.00 (ref.)                   
                            TC             825                  1095                        0.94 (0.86--1.02)                
                            CC             76                   105                         0.91 (0.71--1.16)                  0.12
  rs35767                   GG            4230                  5359                           1.00 (ref.)                   
                            GA            1876                  2468                        0.96 (0.90--1.03)                
                            AA             251                  378                         0.87 (0.76--1.01)                  0.06
  TG                                      5317                  6767                           1.00 (ref.)                   
  TA                                       855                  1148                        0.97 (0.91--1.03)                
  CG                                       100                  129                         1.00 (0.84--1.20)                
  CA                                       390                  531                         0.92 (0.85--1.00)                  0.20
  **Block 2**                                                                                                                
  rs12821878                GG            4073                  5343                           1.00 (ref.)                   
                            GA            2090                  2544                        1.05 (0.99--1.12)                
                            AA             299                  400                         0.98 (0.85--1.12)                  0.38
  rs1019731                 CC            5092                  6639                           1.00 (ref.)                   
                            CA            1404                  1688                        1.05 (0.98--1.13)                
                            AA             97                   145                         0.87 (0.68--1.10)                  0.57
  rs2195239                 CC            3699                  4819                           1.00 (ref.)                   
                            CG            2440                  3121                        1.00 (0.94--1.06)                
                            GG             434                  532                         1.03 (0.91--1.15)                  0.83
  GCC                                     3582                  4691                           1.00 (ref.)                   
  GCG                                     1671                  2121                        1.01 (0.96--1.06)                
  ACC                                      799                  983                         1.03 (0.96--1.10)                
  AAC                                      594                  757                         1.02 (0.95--1.10)                
  Haplotype Freq \<5%                      16                    22                         0.99 (0.61--1.62)                  0.93
  **Block 3**                                                                                                                
  rs10735380                AA            3658                  4716                           1.00 (ref.)                   
                            AG            2502                  3088                        1.03 (0.97--1.10)                
                            GG             425                  595                         0.93 (0.83--1.05)                  0.92
  rs2373722                 GG            5845                  7475                           1.00 (ref.)                   
                            GA             757                  978                         1.00 (0.92--1.10)                
                            AA             26                    47                         0.82 (0.52--1.30)                  0.82
  rs5742665                 CC            5133                  6566                           1.00 (ref.)                   
                            CG            1282                  1674                        1.01 (0.94--1.09)                
                            GG             107                  131                         1.12 (0.89--1.42)                  0.52
  rs1549593                 GG            4994                  6455                           1.00 (ref.)                   
                            GT            1416                  1734                        1.03 (0.96--1.11)                
                            TT             114                  146                         0.98 (0.78--1.22)                  0.57
  rs1520220                 CC            4048                  5277                           1.00 (ref.)                   
                            CG            2207                  2707                        1.03 (0.97--1.10)                
                            GG             329                  440                         0.96 (0.85--1.10)                  0.73
  AGCGC                                   3171                  4127                           1.00 (ref.)                   
  AGCGG                                    322                  395                         0.99 (0.90--1.09)                
  AGCTC                                    697                  858                         1.04 (0.96--1.12)                
  AGGGC                                    766                  991                         1.03 (0.96--1.10)                
  GGCGC                                    434                  574                         0.99 (0.90--1.09)                
  GGCGG                                    719                  893                         1.03 (0.96--1.10)                
  GACGG                                    406                  541                         1.00 (0.91--1.09)                
  Haplotype Freq \<5%                      147                  196                         0.93 (0.79--1.09)                  0.88
  **Block 4**                                                                                                                
  rs2946834                 GG            2857                  3673                           1.00 (ref.)                   
                            GA            2898                  3705                        1.01 (0.95--1.07)                
                            AA             845                  1054                        1.03 (0.94--1.12)                  0.61
  rs4764876                 GG            3315                  4230                           1.00 (ref.)                   
                            GC            2560                  3395                        0.97 (0.92--1.04)                
                            CC             643                  739                         1.08 (0.98--1.20)                  0.47
  rs4764695                 GG            1832                  2373                           1.00 (ref.)                   
                            GA            3188                  4087                        1.02 (0.95--1.09)                
                            AA            1541                  1977                        1.01 (0.93--1.09)                  0.81
  rs1996656                 AA            4512                  5753                           1.00 (ref.)                   
                            AG            1773                  2320                        0.98 (0.91--1.04)                
                            GG             199                  241                         1.04 (0.88--1.23)                  0.72
  GGAA                                    2753                  3506                           1.00 (ref.)                   
  GGGA                                    1006                  1340                        0.96 (0.90--1.02)                
  GGGG                                     429                  567                         0.97 (0.89--1.07)                
  AGAA                                     395                  531                         0.96 (0.88--1.06)                
  ACGA                                    1134                  1411                        1.02 (0.96--1.08)                
  ACGG                                     666                  860                         0.98 (0.91--1.05)                
  Haplotype Freq \<5%                      279                  360                         1.01 (0.90--1.13)                  0.75

Adjusted for age, race/ethnicity, and country within EPIC cohort.

10.1371/journal.pone.0002578.t004

###### Association of tagging SNPs of *IGFBP1* and *IGFBP3* and breast cancer risk in the BPC3.
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  SNP                    Genotype   Cases (n = 6,912)   Controls (n = 8,891)   OR[\*](#nt102){ref-type="table-fn"} (95% CI)   p-trend
  --------------------- ---------- ------------------- ---------------------- ---------------------------------------------- ---------
  **Block 1**                                                                                                                
  rs10228265                AA            3112                  3962                           1.00 (ref.)                   
                            AG            2765                  3637                        0.98 (0.92--1.04)                
                            GG             646                  846                         0.98 (0.89--1.08)                  0.54
  rs1553009                 GG            4273                  5490                           1.00 (ref.)                   
                            GA            2046                  2668                        0.99 (0.93--1.05)                
                            AA             243                  336                         0.93 (0.80--1.08)                  0.419
  rs35539615                CC            2760                  4836                           1.00 (ref.)                   
                            CG            2298                  3073                        0.97 (0.92--1.03)                
                            GG             389                  473                         1.01 (0.90--1.14)                  0.63
  rs2201638                 GG            6118                  7831                           1.00 (ref.)                   
                            GA             497                  706                         0.94 (0.85--1.05)                
                            AA             34                    35                         1.17 (0.81--1.68)                  0.53
  rs1065780                 GG            2441                  3083                           1.00 (ref.)                   
                            GA            2999                  4080                        0.95 (0.89--1.01)                
                            AA            1055                  1282                        1.02 (0.93--1.11)                  0.812
  AGCGG                                   1655                  2070                           1.00 (ref.)                   
  AGGGG                                   1564                  2045                        0.95 (0.90--1.01)                
  AACGA                                   1263                  1667                        0.95 (0.89--1.01)                
  GGCGA                                   1267                  1604                        0.98 (0.92--1.04)                
  GGCGG                                    555                  748                         0.94 (0.87--1.02)                
  GGCAG                                    255                  357                         0.93 (0.83--1.04)                
  AGCGA                                    52                    71                         0.88 (0.69--1.13)                
  Haplotype Freq \<5%                      112                  119                         1.11 (0.94--1.32)                  0.30
  **Block 2**                                                                                                                
  rs4988515                 CC            5933                  7702                           1.00 (ref.)                   
                            CT             627                  782                         1.00 (0.91--1.11)                
                            TT             27                    33                         1.06 (0.69--1.63)                  0.86
  rs4619                    AA            2706                  3456                           1.00 (ref.)                   
                            AG            2964                  3886                        0.98 (0.92--1.04)                
                            GG             907                  1122                        1.01 (0.93--1.11)                  0.94
  rs1908751                 CC            3238                  4134                           1.00 (ref.)                   
                            CT            2677                  3518                        0.98 (0.92--1.04)                
                            TT             593                  758                         0.99 (0.89--1.10)                  0.57
  rs2270628                 CC            4198                  5472                           1.00 (ref.)                   
                            CT            2031                  2606                        1.00 (0.94--1.06)                
                            TT             276                  629                         0.99 (0.86--1.14)                  0.93
  CACC                                    2274                  2926                           1.00 (ref.)                   
  CATC                                    1907                  2477                        0.98 (0.94--1.04)                
  CGCC                                    1198                  1566                        0.98 (0.93--1.04)                
  CGCT                                     901                  1143                        1.00 (0.94--1.07)                
  TGCT                                     348                  434                         0.99 (0.91--1.09)                
  Haplotype Freq \<5%                      95                   136                         0.88 (0.73--1.07)                  0.84
  **Block 3**                                                                                                                
  rs3110697                 GG            2241                  2919                           1.00 (ref.)                   
                            GA            3032                  3967                        1.00 (0.94--1.07)                
                            AA            1191                  1491                        1.04 (0.95--1.13)                  0.47
  rs2854746                 GG            2142                  2759                           1.00 (ref.)                   
                            GC            2983                  3843                        1.01 (0.94--1.08)                
                            CC            1208                  1553                        1.01 (0.93--1.10)                  0.82
  rs2854744                 GG            1751                  2190                           1.00 (ref.)                   
                            GT            3155                  4157                        0.96 (0.90--1.03)                
                            TT            1581                  2011                        0.98 (0.91--1.07)                  0.69
  GCT                                     2778                  3601                           1.00 (ref.)                   
  AGG                                     2707                  3464                        1.01 (0.97--1.06)                
  GGG                                      733                  948                         1.00 (0.93--1.08)                
  GGT                                      382                  513                         0.95 (0.87--1.05)                
  Haplotype Freq \<5%                      122                  155                         1.03 (0.87--1.22)                  0.80
  **Additional SNPs**                                                                                                        
  rs6670                    TT            4210                  5555                           1.00 (ref.)                   
                            TA            2022                  2602                        1.05 (0.98--1.12)                
                            AA             305                  356                         1.12 (0.97--1.30)                  0.05
  rs2453839                 TT            4301                  5516                           1.00 (ref.)                   
                            TC            2012                  2650                        0.99 (0.93--1.05)                
                            CC             274                  354                         1.01 (0.87--1.16)                  0.89
  rs2132570                 GG            3999                  5182                           1.00 (ref.)                   
                            GT            2145                  2772                        0.99 (0.93--1.06)                
                            TT             358                  441                         1.01 (0.89--1.15)                  0.99
  rs2960436                 GG            1795                  2237                           1.00 (ref.)                   
                            GA            3127                  4156                        0.96 (0.89--1.02)                
                            AA            1657                  2128                        0.98 (0.90--1.06)                  0.56

Adjusted for age, race/ethnicity, and country within EPIC cohort

Across all statistical tests performed in relation to disease status, we observed fewer significant findings than those expected by chance alone (15 findings significant at p\<0.05; 40 expected by chance alone). None of these findings provided clear evidence for main effect or subgroup associations for any of the SNPs or common haplotypes. Thus we believe these sporadic associations may reflect chance. Finally, we repeated all analyses excluding subjects from the MEC and EPIC cohorts, and found no meaningful differences in associations when compared to overall findings (data not shown).

Discussion {#s4}
==========

Our study is by far the largest to examine genetic variation in the *IGF1*, *IGFBP1*, and *IGFBP3* genes in relation to both circulating IGF-I and IGFBP-3 levels and breast cancer risk. Several genetic variants in *IGF1* and *IGFBP3* predicted circulating levels of IGF-I and IGFBP-3, respectively, but no associations between these variants and breast cancer, overall or in subgroups, were seen. It is thus unlikely that these polymorphisms and their associated hormone levels substantially affect breast cancer risk. There was also no evidence of effect modification by selected breast cancer risk factors or subgroup effects, including menopausal status. While some previous epidemiologic studies have shown stronger support for a role of the IGF-I signaling pathway in premenopausal breast cancer [@pone.0002578-Fletcher1], but we did not observe an association among premenopausal women alone.

Our findings are consistent with two previous studies that comprehensively examined the role of *IGF1*, *IGFBP1*, and *IGFBP3* genetic variation in relation to circulating IGF-I and IGFBP-3 levels and breast cancer risk [@pone.0002578-Canzian1], [@pone.0002578-Cheng1], [@pone.0002578-Setiawan1]. Cases and controls from these two studies (EPIC and MEC) were included in the pooled analysis. However, sensitivity analyses that excluded these studies also found an association with circulating hormone levels. Other studies have primarily examined individual variants in *IGF1, IGFBP1*, or *IGFBP3* in relation to breast cancer with mixed results [@pone.0002578-Fletcher1], [@pone.0002578-Schernhammer2], [@pone.0002578-Slattery1], [@pone.0002578-Wagner1]. The most extensively studied variant in *IGF1* is the (CA)~n~ repeat polymorphism that lies 1-kb upstream of the *IGF1* transcriptional start site [@pone.0002578-Fletcher1], [@pone.0002578-Wagner1]. Some previous studies observed an association between this polymorphism and circulating IGF-I levels (reviewed in [@pone.0002578-Fletcher1]); however, most did not observe a corresponding association with breast cancer risk. While we did not genotype *IGF1* (CA)~n~ polymorphism, we used data from a prior study [@pone.0002578-DeLellis1] and determined that the less common repeat length for this polymorphism is in LD with the minor alleles of htSNPs in block 1, rs7965399 and rs35767. Thus, our reported associations with htSNPs in block 1 and circulating IGF-I levels appear consistent with previous literature, that genetic variation influences circulating IGF-I levels, but not at a level substantial enough to impact breast cancer risk.

The A/C polymorphism at nucleotide −202 in *IGFBP3* (rs2854744), and located in haplotype block 3, has been the most extensively examined polymorphism in the IGF binding proteins[@pone.0002578-Fletcher1], [@pone.0002578-Canzian1], [@pone.0002578-Cheng1], [@pone.0002578-Schernhammer2], [@pone.0002578-Slattery1], [@pone.0002578-Wagner1]. Some [@pone.0002578-Fletcher1], [@pone.0002578-Schernhammer2], [@pone.0002578-Slattery1], [@pone.0002578-Wagner1] but not all previous studies [@pone.0002578-Fletcher1], [@pone.0002578-Canzian1], [@pone.0002578-Cheng1], [@pone.0002578-Schernhammer2], [@pone.0002578-Slattery1], [@pone.0002578-Wagner1] have reported an association with breast cancer . This polymorphism has also been associated with circulating levels of IGFBP-3 [@pone.0002578-Schernhammer1], [@pone.0002578-Slattery1]. Our study confirms the previously reported findings with circulating IGFBP-3 levels, but neither the polymorphism (within Block 3 of *IGFBP3* gene) nor the haplotype block were associated with breast cancer risk in our data.

Strengths of the BPC3 include its size and the comprehensive characterization of variation around the *IGF1*, *IGFBP1*, and *IGFBP3* loci. The latter allows our analysis to provide powerful null evidence against a main effect association between breast cancer risk and variants in these genes that are common among Caucasian women as well as in defined subgroups of the study population.

In summary, results from this large collaborative study support previous evidence that specific genetic variants in *IGF1* and *IGFBP3* genes significantly influence circulating levels of IGF-I and IGFBP-3, respectively, but have no measurable effect on breast cancer risk. Given the large size of our study, it is unlikely that these loci contribute substantially to breast cancer risk among white, primarily postmenopausal, women, at the population level.
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